TWEAK /Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.70110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Yale Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Cytokine TWEAK, TWEAK Receptor, Lupus Erythematosus, Systemic, Oxidative Stress. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Innovation Capability Support Plan of Shaanxi Health Commission, Key Medical Research Plan of Xi'an City.
Abstract (Originalsprache)
Objective
Cardiac involvement is a major cause of morbidity in systemic lupus erythematosus (SLE). Tumor necrosis factor–like weak inducer of apoptosis (TWEAK) is elevated in SLE, but its contribution to lupus‐associated cardiac injury is unclear. We investigated the role of TWEAK/fibroblast growth factor–inducible 14 (Fn14) signaling in SLE‐related cardiomyopathy and its potential as a biomarker and therapeutic target.
Methods
Serum TWEAK, inflammatory cytokines, autoantibodies, and oxidative stress markers were measured in 242 patients with SLE and 66 age‐ and sex‐matched controls, with correlation to echocardiographic, electrocardiographic, and myocardial enzyme findings. Cardiac pathology and redox signaling were assessed in pristane‐induced lupus models using wild‐type mice and mice deficient of Fn14 by histopathology, immunoblotting, immunofluorescence, and quantitative proteomics. Direct effects of TWEAK on mitochondrial oxidative stress, antioxidant signaling, and apoptosis were examined in primary cardiomyocytes isolated from MRL/lpr mice who were lupus prone.
Results
Serum TWEAK levels were significantly elevated in patients with SLE and were highest in those with cardiac abnormalities compared with healthy controls. TWEAK correlated positively with malondialdehyde, 8‐hydroxy‐2’‐deoxyguanosine, disease activity, and inflammatory cytokines and inversely with superoxide dismutase. Elevated baseline TWEAK predicted new cardiac abnormalities during follow‐up and declined with clinical improvement. In mice with lupus, Fn14 deficiency reduced cardiac reactive oxygen species accumulation, restored Nrf2/HO‐1 antioxidant signaling, attenuated histopathological injury, and preserved cardiac function. In vitro, TWEAK induced mitochondrial superoxide production, suppressed Nrf2 signaling, and promoted apoptosis in lupus‐prone cardiomyocytes.
Conclusion
TWEAK/Fn14 signaling drives oxidative stress–mediated cardiomyocyte injury in SLE and represents a promising biomarker and therapeutic target for lupus‐associated cardiac damage. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Plastic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Dermatology, Northwest University First Hospital, Xi'an, China.
- Department of Dermatology, Xi'an Gaoxin Hospital, Xi'an, China.
ORCID-Profile: Yumin Xia
Förderung
- National Natural Science Foundation of China
- Innovation Capability Support Plan of Shaanxi Health Commission
- Key Medical Research Plan of Xi'an City
- Special Support Program for High-Level Talents of Shaanxi Province
Zitieren
APA
Liu, Y., Yan, Z., Peng, X., Li, M., Wang, J., Zhang, Y., Hu, X., Zhou, M., Ren, K., Zhang, D., Guo, X., Xia, Y., & Huo, H. (2026). TWEAK /Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays. Arthritis & Rheumatology. https://doi.org/10.1002/art.70110
Vancouver
Liu Y, Yan Z, Peng X, Li M, Wang J, Zhang Y, et al. TWEAK /Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays. Arthritis & Rheumatology. 2026. doi:10.1002/art.70110
BibTeX
@article{Liu2026,
author = {Liu, Yale and Yan, Zhu and Peng, Xueting and Li, Meixuan and Wang, Juan and Zhang, Yan and Hu, Xiaoqian and Zhou, Mingzhu and Ren, Kaixuan and Zhang, Dan and Guo, Xingyi and Xia, Yumin and Huo, Huanhuan},
title = {TWEAK /Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70110}
}
EUVIMED